Investigation announced for Investors in Inotiv, Inc. (NASDAQ: NOTV) over potential Wrongdoing

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Inotiv, Inc.

Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Inotiv, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

West Lafayette, IN based Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc reported that its Total Revenue rose from $60.46 million to $89.6 million for the 12 months period that ended on September 30, 2020, and that its Net Loss over those respective time periods increased from $1.49 million to $1.68 million.
According to Seeking Alpha, on May 23, 2022, it was disclosed that a DOJ-backed lawsuit was initiated against a subsidiary of Inotiv, Inc. The legal action is for alleged violations of animal welfare.

On November 17, 2022, in a Form 8-K filed with the United States ("U.S.") Securities and Exchange Commission, Inotiv, Inc. disclosed that, on November 16, 2022, the Company became aware that the U.S. Attorney's Office for the Southern District of Florida criminally charged employees of the Company's principal supplier of non-human primates ("NHPs") with conspiring to illegally import NHPs into the U.S. from December 2017 through January 2022 and in connection with seven specific imports between July 2018 and December 2021.

Shares of Inotiv, Inc (NASDAQ: NOTV) declined from $19.01 per share on May 18, 2022, to as low as $4.04 per share on April 6, 2023.

Those who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.